An study to evaluate the efficacy of virechana(purgation) and basti (enema) followed by vishwadi dwadashanga kwatha (decoction) in the management of fibromyalgia ?.
Phase 2
Completed
- Conditions
- Health Condition 1: M628- Other specified disorders of muscle
- Registration Number
- CTRI/2022/05/042676
- Lead Sponsor
- ational Institute of Ayurveda
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 32
Inclusion Criteria
1.Patients between 18 and 65 years of age.
2.Patients with the clinical features of Mamsagata Vata.
3.Patients with the clinical features of Fibromyalgia.
4.Patients fit for Virechana Karma and Niruha Basti.
5.Chronicity less than 10 years.
Exclusion Criteria
1.Patient, suffering from any chronic debilitating disease like T.B., Varicose vein, Asthma, Rheumatoid Arthritis & other chronic problems etc. and having other serious pathology.
2.Patients suffering from systemic disorders as cardiac problem, uncontrolled Diabetes Mellitus, Uncontrolled Hypertension, Paralysis, Malignancy, HIV, HBsAg, Leprosy.
3.Pregnant women and lactating mother.
4.Associated with simple or compound fractures.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method changes in American College of Rheumatology (ACR): Preliminary Criteria for FibromyalgiaTimepoint: assessment will be done on 0thday, 16th day, 31st day.
- Secondary Outcome Measures
Name Time Method 1. Changes in FIBROMYALGIA IMPACT QUESTIONNAIRE (FIQ). <br/ ><br>2.VAS-SCALE.: VAS have been recommended: no pain (0–4 mm), mild pain (5-44 mm), <br/ ><br>moderate pain (45–74 mm), and severe pain (75–100 mm) <br/ ><br>Timepoint: assessment will be done on 0thday, 16th day, 31st day.